Multiple sclerosis and disease-modifying therapies

被引：4
|
作者：
Minen, Mia T.
Karceski, Steven
机构：
来源：
NEUROLOGY | 2011年 / 77卷 / 04期
关键词：
D O I：
10.1212/WNL.0b013e318229e6ca
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E26 / E26
页数：1
相关论文
共 50 条
  • [41] Herpes Zoster Infections With Multiple Sclerosis Disease-Modifying Therapies
    Balshi, Alexandra
    Leuenberger, Grace
    Dempsey, John
    Manning, Nova
    Baber, Ursela
    Sloane, Jacob A.
    NEUROLOGY-CLINICAL PRACTICE, 2025, 15 (02)
  • [42] Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies
    McGinley, Marisa P.
    Cola, Philip A.
    Fox, Robert J.
    Cohen, Jeffrey A.
    Corboy, John J.
    Miller, Deborah
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (12) : 1581 - 1589
  • [43] Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
    Ali Manouchehrinia
    Cris S. Constantinescu
    Current Neurology and Neuroscience Reports, 2012, 12 : 592 - 600
  • [44] Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis
    Zanga, Gisela
    Drzewiscki, Estefania
    Tagliani, Paula
    Smietniansky, Maximiliano
    Rojas, Maria M. Esnaola y
    Caruso, Diego
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [45] Adherence to Multiple Sclerosis Disease-Modifying Therapies in Ontario is Low
    Wong, Janice
    Gomes, Tara
    Mamdani, Muhammad
    Manno, Michael
    O'Connor, Paul W.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2011, 38 (03) : 429 - 433
  • [46] Addressing the Rising Prices of Disease-Modifying Therapies for Multiple Sclerosis
    Hartung, Daniel M.
    Bourdette, Dennis
    JAMA NEUROLOGY, 2019, 76 (11) : 1285 - 1287
  • [47] The evolution of multiple sclerosis disease-modifying therapies: An update for pharmacists
    Edinger, Alexandra
    Habibi, Mitra
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (02) : 37 - 55
  • [48] Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
    Manouchehrinia, Ali
    Constantinescu, Cris S.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (05) : 592 - 600
  • [49] Commentary on: Comparing the efficacy of disease-modifying therapies in multiple sclerosis
    Tsivgoulis, Georgios
    Katsanos, Aristeidis H.
    Voumvourakis, Konstantinos
    Hadjigeorgiou, Georgios M.
    Heliopoulos, Ioannis
    Karapanayiotides, Theodore
    Grigoriadis, Nikolaos
    Papathanasopoulos, Panagiotis
    Kilidireas, Constantinos
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 21 : 117 - 119
  • [50] Oral Disease-Modifying Therapies for Multiple Sclerosis: Are We There Yet?
    Vijayshree Yadav
    Dennis Bourdette
    Current Neurology and Neuroscience Reports, 2010, 10 (5) : 333 - 335
12345